Bessemer Group Inc. trimmed its holdings in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 17.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 52,000 shares of the medical instruments supplier’s stock after selling 11,200 shares during the period. Bessemer Group Inc.’s holdings in AngioDynamics were worth $865,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. SG Americas Securities LLC bought a new stake in shares of AngioDynamics during the third quarter worth approximately $143,000. Trexquant Investment LP bought a new stake in shares of AngioDynamics during the third quarter worth approximately $175,000. Teachers Retirement System of The State of Kentucky raised its stake in shares of AngioDynamics by 54.9% during the second quarter. Teachers Retirement System of The State of Kentucky now owns 11,000 shares of the medical instruments supplier’s stock worth $178,000 after buying an additional 3,900 shares during the last quarter. GSA Capital Partners LLP raised its stake in shares of AngioDynamics by 74.7% during the second quarter. GSA Capital Partners LLP now owns 18,706 shares of the medical instruments supplier’s stock worth $303,000 after buying an additional 7,999 shares during the last quarter. Finally, Thrivent Financial For Lutherans raised its stake in shares of AngioDynamics by 13.4% during the second quarter. Thrivent Financial For Lutherans now owns 20,610 shares of the medical instruments supplier’s stock worth $334,000 after buying an additional 2,430 shares during the last quarter. 94.75% of the stock is owned by institutional investors and hedge funds.

Shares of AngioDynamics, Inc. (ANGO) opened at $16.13 on Friday. AngioDynamics, Inc. has a 12 month low of $14.80 and a 12 month high of $18.85. The company has a quick ratio of 1.65, a current ratio of 2.56 and a debt-to-equity ratio of 0.17. The company has a market cap of $611.81, a P/E ratio of -76.81, a price-to-earnings-growth ratio of 1.54 and a beta of 0.98.

AngioDynamics (NASDAQ:ANGO) last issued its earnings results on Thursday, January 4th. The medical instruments supplier reported $0.16 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.16. AngioDynamics had a negative net margin of 2.27% and a positive return on equity of 4.63%. The firm had revenue of $86.70 million during the quarter, compared to the consensus estimate of $88.15 million. During the same quarter in the prior year, the firm earned $0.19 earnings per share. The business’s quarterly revenue was down 2.6% on a year-over-year basis. equities research analysts forecast that AngioDynamics, Inc. will post 0.72 EPS for the current fiscal year.

A number of equities research analysts recently weighed in on the stock. BidaskClub raised shares of AngioDynamics from a “sell” rating to a “hold” rating in a research note on Monday, February 5th. Zacks Investment Research downgraded shares of AngioDynamics from a “buy” rating to a “hold” rating in a research note on Friday, January 26th. Craig Hallum downgraded shares of AngioDynamics from a “buy” rating to a “hold” rating in a research note on Friday, January 5th. Finally, TheStreet downgraded shares of AngioDynamics from a “b-” rating to a “c” rating in a research note on Tuesday, January 2nd. Six research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. AngioDynamics currently has a consensus rating of “Hold” and a consensus target price of $18.60.

TRADEMARK VIOLATION NOTICE: This article was posted by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.dailypolitical.com/2018/02/10/bessemer-group-inc-sells-11200-shares-of-angiodynamics-inc-ango.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Want to see what other hedge funds are holding ANGO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AngioDynamics, Inc. (NASDAQ:ANGO).

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with MarketBeat.com's FREE daily email newsletter.